Key Takeaways
- The current market environment is forcing a distinction between speculative growth and quality growth, with investors increasingly favouring companies demonstrating clear operational leverage and a path to profitability.
- Digital health platforms like Hims & Hers are evolving from high-growth cash-burn models into profitable enterprises, signalling a maturation of the sector and challenging earlier assumptions about margin pressure.
- While AI infrastructure remains a central theme, the performance divergence between hardware providers (like AMD) and application layers (like Palantir) highlights different risk exposures to capital expenditure cycles and valuation concerns.
- Portfolio construction in technology now requires a more granular approach, balancing secular growth narratives against sensitivities to macroeconomic factors like persistent inflation and borrowing costs.
A subtle but significant shift appears to be underway within technology and growth portfolios. As the market navigates a complex environment of stubborn inflation and uncertain monetary policy, a flight to quality is taking shape, not by abandoning growth entirely, but by redefining it. The focus is pivoting from revenue growth at any cost towards businesses that exhibit durable demand, operational leverage, and, most critically, a demonstrable line of sight to sustainable profitability. This recalibration is particularly evident across key sub-sectors like artificial intelligence infrastructure, enterprise AI applications, and digital health, where the leaders of tomorrow are being separated from the speculative stories of yesterday.
Divergence in the AI Ecosystem
The artificial intelligence trade, whilst still dominant, is showing signs of fragmentation. The initial wave saw a correlated rise across the ecosystem, but investors are now applying a finer lens, creating a divergence between the picks-and-shovels providers and the application layer specialists. Companies at the infrastructure level, such as Advanced Micro Devices (AMD), continue to benefit from the immense capital expenditure directed at data centres. AMD’s strategic positioning with its MI300 series of accelerators provides a credible, albeit distant, challenge to Nvidia’s market dominance, and its data centre revenue remains a powerful growth engine. However, this segment is not without its vulnerabilities, being highly sensitive to corporate capital budgets which could face scrutiny in a prolonged high-rate environment.
Conversely, companies in the AI applications space, such as Palantir Technologies (PLTR), face a different set of challenges. While Palantir has made significant inroads into the commercial sector with its Artificial Intelligence Platform (AIP), its valuation remains a topic of vigorous debate. The market is weighing its impressive commercial growth against its historical reliance on government contracts and the high levels of stock-based compensation. For these firms, the narrative is no longer just about technological potential but about the economic viability and scalability of their business models in a more discerning market.
From Cash Burn to Profitability: The Digital Health Litmus Test
Perhaps the most compelling evidence of this market shift can be found in the digital health sector. For years, companies like Hims & Hers Health (HIMS) were viewed through a lens of scepticism, praised for rapid top-line growth but persistently questioned on marketing spend and long-term profitability. The narrative was one of a land grab, funded by a seemingly endless supply of cheap capital. That chapter appears to be closing. Hims & Hers recently achieved a significant milestone by reporting its first quarter of GAAP profitability in early 2024, a feat it repeated with stronger results in the following quarter. Net income turned positive, and adjusted EBITDA margins expanded, suggesting the business model is reaching an inflection point where economies of scale are finally taking hold. (1)
This transition is crucial. It signals that a business built on high customer acquisition costs can mature into a self-sustaining enterprise. For investors, this changes the entire risk-reward calculation. The company is no longer a speculative bet on a future concept but an operating business demonstrating financial discipline. This accomplishment is particularly noteworthy given the broader economic backdrop and may serve as a blueprint for other direct-to-consumer growth companies.
| Company | Ticker | Primary Thesis | Key Metric / Recent Development |
|---|---|---|---|
| Advanced Micro Devices, Inc. | AMD | A key beneficiary of data centre and AI build-out, providing a competitive alternative in the high-performance computing market. | Data Centre revenue grew 80% year-over-year to $2.3 billion in its most recent quarter, driven by demand for Instinct GPUs and EPYC CPUs. (2) |
| Hims & Hers Health, Inc. | HIMS | A digital health platform transitioning from high growth to sustainable profitability by leveraging brand recognition and scale. | Achieved second consecutive quarter of GAAP profitability in Q2 2024, with net income of $11.2 million and a 41% year-over-year revenue increase. (1) |
| Palantir Technologies Inc. | PLTR | An enterprise software firm leveraging its AI platform for expansion into the commercial sector, diversifying from its government base. | US commercial revenue grew 40% year-over-year in Q2 2024, with its US commercial customer count increasing by 51%. (3) |
Portfolio Implications in a New Growth Paradigm
The overarching theme is one of discernment. The era of indiscriminately buying baskets of “innovation” stocks is over. The current environment calls for a more granular analysis, questioning the durability of moats and the credibility of paths to positive cash flow. While a stagflationary outlook presents challenges for all equities, it disproportionately punishes companies without pricing power or with bloated cost structures. (4)
For allocators, this means digging deeper into financial statements and moving beyond headline revenue figures. The key questions have changed: Is growth profitable? Are margins expanding? Is the company’s reliance on external capital diminishing? The answers to these questions are likely what is driving the subtle rebalancing acts we are seeing in specialist portfolios. The speculative hypothesis, therefore, is not about the next hot sector, but about the impending market-wide repricing between two types of growth: the kind that is funded by debt and dilution, and the kind that is funded by customers. As this reappraisal continues, the performance gap between these two cohorts is likely to widen significantly.
References
(1) Hims & Hers Health, Inc. (2024, August 5). Hims & Hers Reports Second Quarter 2024 Financial Results. Hims & Hers Investor Relations. Retrieved from https://investors.hims.com/news-releases/news-release-details/hims-hers-reports-second-quarter-2024-financial-results
(2) Advanced Micro Devices, Inc. (2024, July 30). AMD Reports Second Quarter 2024 Financial Results. AMD Investor Relations. Retrieved from https://ir.amd.com/news-events/press-releases/detail/1209/amd-reports-second-quarter-2024-financial-results
(3) Palantir Technologies Inc. (2024, August 5). Palantir Reports Q2 2024 Results. Palantir Investor Relations. Retrieved from https://investors.palantir.com/news-details/2024/Palantir-Reports-Q2-2024-Results
(4) Cording, J., & D’Anca, A. (2024, May 29). Confronting the new economic reality. McKinsey & Company. Retrieved from https://www.mckinsey.com/mgi/our-research/confronting-the-new-economic-reality
